Endocrinology and Metabolism10.3803/enm.2015.30.4.4752015304475Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in KoreaHee Kyung Kim, Jee Hee Yoon, Min Ji Jeon, Tae Yong Kim, Young Kee Shong, Min Jin Lee, Bo Hyun Kim, In Joo Kim, Ji Young Joung, Sun Wook Kim, Jae Hoon Chung, Ho-Cheol Kang,,
Thyroid10.1089/1050725043231507872004146459-462Antithyroid Drug-Induced Agranulocytosis: Special Reference to Normal White Blood Cell Count AgranulocytosisJunichi Tajiri, Shiro Noguchi
Thyroid10.1089/thy.2000.10.1032000101103-103Use of Colony-Stimulating Factors for the Treatment of Antithyroid Drug-Induced Agranulocytosis: A Retrospective Study in Twelve PatientsEmmanuel Andrès, Frédéric Maloisel, Anne Ruellan
Endocrine Practice10.4158/ep11339.cr2012184e69-e72Delayed Antithyroid Drug-Induced AgranulocytosisPriscilla Mutharasan, Wendy Oatis, Hau Kwaan, Mark Molitch,,
Journal of the Chinese Medical Association10.1016/s1726-4901(09)70402-22009728438-441Antithyroid Drug-induced AgranulocytosisMing-Tsung Sun, Chen-Hao Tsai, Kuang-Chung Shih,,
Reactions Weekly10.1007/s40278-017-34269-3201716631287-287Thiamazole,,
Nature Reviews Endocrinology10.1038/nrendo.2016.812016127374-374Genetic insight into antithyroid drug-induced agranulocytosis in a European populationDavid Holmes,,
Thyroid10.1089/thy.1999.9.2919999129-31Granulocyte Colony-Stimulating Factor (G-CSF) Does Not Improve Recovery from Antithyroid Drug-Induced Agranulocytosis: A Prospective StudySHUJI FUKATA, KANJI KUMA, MASAHIRO SUGAWARA
Thyroid10.1089/thy.2018.02742019292193-201Increased Risk of Antithyroid Drug Agranulocytosis Associated with Amiodarone-Induced Thyrotoxicosis: A Population-Based Cohort StudyMichal Gershinsky, Walid Saliba, Idit Lavi, Chen Shapira, Naomi Gronich,
Endocrine Practice10.1016/s1530-891x(20)44818-9201622287-288Abstract #1171: Antithyroid Drug Induced Agranulocytosis: A Rare but Serious Complication Can Have a Very Late PresentationAisha Sheikh,